
SA Tuberculosis Vaccine Initiative
67 FOLLOWERS
Innovative and high quality TB Vaccine research in Africa to impact the Global epidemic.
SA Tuberculosis Vaccine Initiative | Latest News
1y ago
SATVI is inviting applications for several Laboratory Technologist positions at its Cape Town (2 positions) and Worcester field site laboratories (1 position).  ..read more
SA Tuberculosis Vaccine Initiative | Latest News
1y ago
On World TB Day, the University of Cape Town (UCT) shines the spotlight on phase three of a clinical trial led by clinicians at the South African Tuberculosis Vaccine Initiative (SATVI). The study aims to explore and assess the safety, immunogenicity and efficacy of the novel MTBVAC as a potential TB vaccine alternative to the age-old bacille Calmette-Guerin (BCG), currently administered at birth to protect babies from TB.  ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
Researchers from SATVI have just published results from a study using cutting edge-technology to identify new targets for novel TB vaccine candidates ..read more
SA Tuberculosis Vaccine Initiative
2y ago
We are in the process of upgrading our website. There will be a delay in updates to our website as we relocate the existing content to the new website platform.  ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
We are inviting applications for a postdoctoral fellowship in single cell clinical immunology. The successful candidate will perform single cell RNA sequencing, CITE-seq and analysis on samples collected postmortem from humans as part of a multi-center study. The successful candidate will contribute to study and scientific design, development and performance of lab assays and computational data analyses. Closing date: 30 November 2022 ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
We are inviting applications for a postdoctoral fellowship in human immunology to conduct research aimed at identifying systemic and lung immune signatures of protection from natural M.tb infection and tuberculosis disease in a multi-cohort study. The successful candidate will assist with the design, development, performance and analysis of mass and flow cytometry-based assays in human cells collected by broncho-alveolar lavage and peripheral blood. Closing Date 15 December 2022 ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
For 2022 Mandela day the SATVI has supported several local community-based organisations including House of Hope, support for mothers and children of gender-based violence, Sinethemba HIV organisation, Three Pillars Family Fellowships, Worcester South Day care Centre, Julie Naude Creche and De Doorns Clinic ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
Interim data from a multi-site study conducted to assess the diagnostic accuracy of a new finger stick blood test for TB have just been published in the Clinical Infectious Diseases journal. In this study conducted at multiple clinical research sites, the research shows that the Cepheid 3-gene host-response test, a blood transcriptomic signature, met the minimal target product profile criteria for a point-of-care triage test for TB regardless of geographic area or HIV infection ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
The SATVI Annual Report 2021 is available for download.  ..read more
SA Tuberculosis Vaccine Initiative | Latest News
2y ago
Dr Angelique Kany Kany Luabeya writes in an opinion piece that we should not wait for a COVID-like crisis to act, but we should harness the partnerships from this pandemic to fight the TB pandemic.  ..read more